Vol 14: Combination treatment with doxorubicin and gamitrinib synergistically augments anticancer activity through enhanced activation of Bim.Reportar como inadecuado



 Vol 14: Combination treatment with doxorubicin and gamitrinib synergistically augments anticancer activity through enhanced activation of Bim.


Vol 14: Combination treatment with doxorubicin and gamitrinib synergistically augments anticancer activity through enhanced activation of Bim. - Descarga este documento en PDF. Documentación en PDF para descargar gratis. Disponible también para leer online.

Descargar gratis o leer online en formato PDF el libro: Vol 14: Combination treatment with doxorubicin and gamitrinib synergistically augments anticancer activity through enhanced activation of Bim.
This article is from BMC Cancer, volume 14.AbstractBackground: A common approach to cancer therapy in clinical practice is the combination of several drugs to boost the anticancer activity of available drugs while suppressing their unwanted side effects. In this regard, we examined the efficacy of combination treatment with the widely-used genotoxi

Autor: Park, Hye-Kyung; Lee, Ji-Eun; Lim, Jaehwa; Jo, Da-Eun; Park, Soo-Ah; Suh, Pann-Ghill; Kang, Byoung Heon

Fuente: https://archive.org/



DESCARGAR PDF




Documentos relacionados